Jump to: What is Mounjaro? | Nausea and vomiting | Constipation and diarrhoea | Rare side effects | Take home message
The most common side effects of Mounjaro (tirzepatide) are nausea, constipation, vomiting, and other symptoms affecting the gastrointestinal (GI) tract, like diarrhoea. You might also experience less common side effects like tiredness or headaches.
These symptoms most commonly occur around the time of the injection, during dose escalation, and are typically transient and will ease after you’ve adapted to the medication.
However, everyone responds differently to these medications; some people won’t experience any side effects, while others will have to discontinue their medication due to the discomfort the side effects cause.
Previous research on GLP-1 medications has suggested a possible link to rare and more severe side effects such as pancreatitis and thyroid cancer.
However, no research has found a connection between tirzepatide and pancreatitis or thyroid cancer.
What is Mounjaro?
Mounjaro is a dual-action type 2 diabetes medication. It’s a GLP-1 receptor agonist (like Wegovy and Ozempic) that reduces appetite to support weight loss and improve blood glucose control.
Mounjaro is also a glucose-dependent insulinotropic polypeptide (GIP) mimetic– GIP is a hormone in the body that supports blood glucose levels and helps our fat cells store more excess energy we might consume in our diets.
So, Mounjaro has a dual function that mimics two hormones in the body that support blood glucose levels and weight loss.
Mounjaro is manufactured by Eli Lilly; the active ingredient in Mounjaro is tirzepatide.
Not a magic pill
Weight-loss injections are designed as additional tools for weight management interventions and shouldn’t be considered lifelong medications.
Instead, they should be used to help you kickstart your weight loss and healthy journey while you commit to living a healthier lifestyle.
Consider the use of antidepressants for people living with depression. They’re not designed to cure the condition. Instead, they’re designed to allow room for therapy to treat the condition’s underlying cause.
Mounjaro, and other weight loss injections, like Ozempic and Wegovy, are similar. They can allow you to make lifestyle changes to support long-term weight loss maintenance.
Mounjaro can help silence food-related thoughts and also give you a boost of confidence with more immediate weight-loss results.
This helps to buy you the time and headspace to understand why your body may have struggled to lose weight previously, and to build new long-term healthy habits.
The core focus of our medication programmes is to calm down the feeling of food noise, lower your cravings, and allow you to build healthier habits to keep the weight off for good.
The ultimate goal is to make losing weight feel second nature.
Keep reading as we dig into the side effects of Mounjaro and how to manage them.
1) Nausea and vomiting
Nausea is the most common side effect of Mounjaro and occurs in 13-25% of individuals on the medication. The incidence is dose-dependent, so the higher the dose, the more likely you will experience nausea.
However, it’s typically transient and eases after the body has adapted to the medication or the higher dose you’ve started.
Vomiting is also common when taking tirzepatide, affecting 5-14% of patients on the medication.
Both of these side effects are mainly attributed to the impact of GLP-1 medications to slow down gastric emptying and cause gut distension (enlargement). GLP-1s also communicate with our nervous system, which can disrupt signalling pathways.
These physiological effects mean food takes much longer to pass through our digestive system.
Nausea and vomiting appear to be most common when people overeat or potentially overeat fat which also slows down gastric emptying and could further worsen symptoms.
Here are some tips to reduce nausea and the risk of vomiting on Mounjaro:
- Eat smaller meals
- Eat slowly and mindfully
- You might need to include snacks in-between your three main meals to ensure you’re eating enough
- Stay hydrated
- Avoid foods that previously made you nauseous
- Record a food diary of foods you notice trigger symptoms
- Eat simple meals based on a good source of protein, complex carbohydrates, fruit or vegetables, and some fat
- Don’t lie down after your meal; maybe opt for a short walk
- Avoid eating too close to bedtime
- Speak to your doctor or prescribing physician if symptoms persist or become too uncomfortable
2) Constipation and diarrhoea
Diarrhoea is the second-most-common side effect of Mounjaro, affecting 8-21% of participants. Constipation is less common, occurring in 6-9%.
Constipation may occur due to reduced muscle contractions in the colon when taking the medication. The causes of diarrhoea on Mounjaro aren’t fully understood.
However, these side effects are typically transient and ease after the body has adapted to the medication or the higher dose you’ve started.
Here are some tips to reduce constipation and diarrhoea on Mounjaro:
- Stay hydrated
- Eat a wide variety of fibre sources (nuts, seeds, fruits, vegetables, legumes)
- Exercise and move regularly
- Go to the toilet when needed (don’t try to hold it in)
- Adopt a proper toilet position and place your feet on a stool to help your bowel movements
- Experiment with probiotics and fermented foods like yoghurt, kimchi, fermented beetroot, or kombucha
- Speak to your doctor or prescribing physician if symptoms persist or become too uncomfortable
3) Rare side effects
Thyroid cancer and thyroid-related disorders
A recent meta-analysis (a study reviewing many studies on one topic) analysed the risk of thyroid cancer (and other thyroid-related conditions) associated with the use of GLP-1 receptor agonists like semaglutide (Wegovy) and liraglutide (Saxenda).
The results indicated that liraglutide (Saxenda) slightly increases the risk of thyroid-related disorders compared to placebo.
This is well-documented in the literature, and individuals with a family history of thyroid cancers and related disorders shouldn’t take liraglutide.
Another GLP-1 dulaglutide was also shown to increase the risk of thyroid cancer and related disorders. It’s essential to note that these are rare side effects, and the overall risk is still minimal.
However, a systematic review and meta-analysis of 10 trials in 6,836 participants reviewed the adverse events and most common side effects of tirzepatide.
There were no reported cases of thyroid cancer, or thyroid-related conditions, related to tirzepatide.
Pancreatitis and pancreatic cancer
Despite the current guidelines against individuals with a history of pancreatic cancer or pre-existing pancreatic conditions, there’s no evidence that tirzepatide increases the risk of pancreatitis or pancreatic cancer.
A systematic review and meta-analysis of 10 trials in 6,836 participants reviewed the adverse events and most common side effects of tirzepatide. There were no reported cases of acute pancreatitis related to tirzepatide.
Still, a potential link between pancreatic function and tirzepatide can’t be completely ruled out. But based on the currently available data, it doesn’t seem to increase the risk of these conditions.
Additionally, using tirzepatide has been shown to significantly improve insulin sensitivity and the ability of pancreatic beta-cells to produce and secrete insulin.
So, it’s likely that the benefits to glucose management and insulin sensitivity observed with tirzepatide outweigh any potential risks associated with pancreatitis for most people.
Fatigue
A systematic review and meta-analysis of 10 trials in 6,836 participants reviewed the adverse events and most common side effects of tirzepatide. There were no reported cases of fatigue related to tirzepatide.
However, researchers conducted exit interviews with patients on Mounjaro to collect qualitative data on their experience.
Fatigue was reported by a few patients, with one saying, ‘I got real slow, like lazy. I don’t know what it was, but I was tired or whatever’.
Online community forums also suggest that fatigue seems to be a side effect people are experiencing.
There are a few possible explanations why tirzepatide may lead to fatigue (important: this is speculation at the moment; research has yet to be conducted to test these theories):
- GLP-1s interact with an area of the brain called the hypothalamus; this regulates our sleep-wake cycle. The interaction between tirzepatide and the hypothalamus may disrupt the regulation of our sleep-wake cycle, causing fatigue.
- Tirzepatide may reduce appetite to such an extent that people don’t consume enough calories; this reduces the energy available to the body for essential functions
Here are our top tips to prevent and manage fatigue on Mounjaro:
- Eat enough in your meals, and include snacks in between if needed
- Ensure a source of protein at each meal
- Aim to eat 5-9 servings of fruit and vegetables a day and cook your vegetables to make them easier to digest
- Stay hydrated
- Exercise and move regularly
- Consider taking a multivitamin
- Get daylight exposure, particularly in the morning
- Aim to sleep 7-9 hours per night
- Avoid caffeine after midday if you’re caffeine sensitive
- Speak to your doctor or prescribing physician if symptoms persist or become too uncomfortable
Second Nature’s medication-supported programmes
Second Nature has two medication-supported programmes: a Wegovy weight-loss programme and a Mounjaro weight-loss programme.
If you’ve made the decision to try Wegovy or Mounjaro (assuming you’re eligible), why should you choose Second Nature over other medication providers?
For peace of mind.
Second Nature has worked with the NHS for over 6 years providing weight-loss programmes across the UK.
Whilst our Wegovy and Mounjaro weight-loss programmes are private and not currently used by the NHS, we’ve built the programmes with a focus on scientific evidence, patient safety, and data security.
We hope that our 6+ years of working with the NHS and building a track record of effective weight-loss results will give you peace of mind to give us a try.
